Skip to main content
All Reports

Parkinson's Research — 2026-09-18

September 18, 2026

•

4 sections

•

8 findings

Clinical Trials

  • OnabotulinumtoxinA for Painful Foot Dystonia in Parkinson Disease

    The indexed record describes research on onabotulinumtoxina for painful foot dystonia in parkinson disease: a randomized, double-blind, placebo-controlled trial. . The abstract is available in the original source; this summary does not infer a treatment benefit.

    Research studyLevel: unknownNot available in indexed metadata

    What the study tells us: It helps families and researchers track the question being studied without treating an index record as proof of benefit.

    Limit: The original source is required for the full design, results, and limitations.

    Source: pubmed.ncbi.nlm.nih.gov
  • Effects of Aquatic Tai Chi and Computer Assisted Rehabilitation Enviro

    The indexed record describes research on effects of aquatic tai chi and computer assisted rehabilitation environment-based virtual reality training on rehabilitation in patients with parkinson disease: a randomized controlled trial.. The abstract is available in the original source; this summary does not infer a treatment benefit.

    Research studyLevel: unknownNot available in indexed metadata

    What the study tells us: It helps families and researchers track the question being studied without treating an index record as proof of benefit.

    Limit: The original source is required for the full design, results, and limitations.

    Source: pubmed.ncbi.nlm.nih.gov

Breakthrough Treatments

  • Why do some patients adhere worse? The role of frailty and depression

    The indexed record describes research on why do some patients adhere worse? the role of frailty and depression in parkinson disease.. The abstract is available in the original source; this summary does not infer a treatment benefit.

    Research studyLevel: unknownNot available in indexed metadata

    What the study tells us: It helps families and researchers track the question being studied without treating an index record as proof of benefit.

    Limit: The original source is required for the full design, results, and limitations.

    Source: pubmed.ncbi.nlm.nih.gov
  • A Fokker-Planck framework for control of epidemics

    The indexed record describes research on a fokker-planck framework for control of epidemics.. The abstract is available in the original source; this summary does not infer a treatment benefit.

    Research studyLevel: unknownNot available in indexed metadata

    What the study tells us: It helps families and researchers track the question being studied without treating an index record as proof of benefit.

    Limit: The original source is required for the full design, results, and limitations.

    Source: pubmed.ncbi.nlm.nih.gov

Lifestyle Interventions

  • Towards the Prevention of Freezing of Gait in Parkinson's Disease

    The indexed record describes research on towards the prevention of freezing of gait in parkinson's disease.. The abstract is available in the original source; this summary does not infer a treatment benefit.

    Research studyLevel: unknownNot available in indexed metadata

    What the study tells us: It helps families and researchers track the question being studied without treating an index record as proof of benefit.

    Limit: The original source is required for the full design, results, and limitations.

    Source: pubmed.ncbi.nlm.nih.gov
  • Knowledge structure and frontier trends of exercise interventions for

    The indexed record is about knowledge structure and frontier trends of exercise interventions for parkinson’s disease: a bibliometric and visualized analysis. The available metadata is not enough to judge effectiveness or safety.

    Research studyLevel: unknownNot available in indexed metadata

    What the study tells us: It helps families and researchers track the question being studied without treating an index record as proof of benefit.

    Limit: The original source is required for the full design, results, and limitations.

    Source: europepmc.org

Emerging Research

  • Regulatory endorsement for the application of α-synuclein seed amplifi

    The indexed record describes research on regulatory endorsement for the application of α-synuclein seed amplification assay as a susceptibility and risk biomarker for clinical trials targeting synucleinopathies.. The abstract is available in the original source; this summary does not infer a treatment benefit.

    Research studyLevel: unknownNot available in indexed metadata

    What the study tells us: It helps families and researchers track the question being studied without treating an index record as proof of benefit.

    Limit: The original source is required for the full design, results, and limitations.

    Source: pubmed.ncbi.nlm.nih.gov
  • Glucocerebrosidase dysfunction in GBA1 carriers

    The indexed record describes research on glucocerebrosidase dysfunction in gba1 carriers: insights from blood and macrophage analyses.. The abstract is available in the original source; this summary does not infer a treatment benefit.

    Research studyLevel: unknownNot available in indexed metadata

    What the study tells us: It helps families and researchers track the question being studied without treating an index record as proof of benefit.

    Limit: The original source is required for the full design, results, and limitations.

    Source: pubmed.ncbi.nlm.nih.gov

This report is for informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

← All ReportsFree, updated daily